US Veterinary Vaccines Industry Size

The report "US Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031" is projected to grow from USD 4.67 billion in 2026 and to reach USD 6.50 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.

Browse 251 market data Tables and 60 Figures spread through 300 Pages and in-depth TOC on "US Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/us-veterinary-vaccines-market-128182859.html

The growing global awareness regarding animal health, increasing pet population and pet ownership, initiatives by various governments to improve animal health, and growing adoption of pet insurance policies are propelling the adoption of veterinary vaccines in the US. A large number of pet owners are purchasing pet insurance because of the significant growth in pet care expenditure in recent years, which is also boosting the veterinary vaccines market in the US. Additionally, the increasing focus on new and advanced product development and growing adoption of veterinary vaccines in the US  are expected to support the US veterinary vaccines market growth during the forecast period. However, the high cost associated with vaccines is likely to hamper the development of the US veterinary vaccines market.

The companion animal vaccines segment is estimated to register the highest growth rate in the global US veterinary vaccines market in 2026.

By type, the companion animal vaccines segment is growing significantly, driven by increasing pet ownership, heightened awareness of preventive healthcare, and the development of more effective and safer vaccines. As pets are increasingly viewed as family members, the demand for vaccinations to protect them from infectious diseases is rising. Additionally, the growing recognition of zoonotic disease risks, government regulations, and the rise of pet insurance are further boosting vaccine demand.

The veterinary hospitals segment is estimated to grow at a significant rate in the US veterinary vaccines market in 2026.

By end user, the veterinary hospitals segment is projected to grow at a significant rate in 2026. The segment is growing quickly as more pet owners seek professional care for their pets. With pets being treated like family, owners turn to veterinary hospitals for vaccinations and overall health care. These hospitals offer advanced vaccines and follow-up care, which makes them a go-to choice for ensuring pets stay healthy. Moreover, partnerships between pharmaceutical companies and the growing focus on preventive care are also helping the growth of this segment. As a result, veterinary hospitals are becoming an increasingly important part of the pet healthcare landscape.

The US veterinary vaccines market is experiencing rapid growth driven by rising pet ownership, increasing awareness of pet health, and growing disposable incomes. As more people adopt pets, there is a rising demand for veterinary care, including vaccinations. The expansion of veterinary hospitals, along with government initiatives to improve animal health and prevent zoonotic diseases, is further boosting vaccine adoption. This combination of factors makes the US one of the fastest-growing markets for veterinary vaccines.

Key players dominating the US veterinary vaccines market are Zoetis (US), Merck & Co, Inc. (US), Boehringer Ingelheim International GmbH (Germany), Elanco (US), Virbac (France), Ceva (France), Phibro Animal Health Corporation (US), Hester Biosciences Limited (India), Neogen Corporation (US), HIPRA (Spain), and Biogénesis Bagó (Argentina), among others.

Don’t miss out on business opportunities in US Veterinary Vaccines Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/